印度重症患者碳青霉烯耐药肠杆菌感染管理共识(ICONIC)- 印度
该共识由印度11位CRE感染多学科专家组成小组,通过系统文献回顾和改良Delphi法匿名投票60个临床问题,最终形成46条关键临床共识声明。共识涵盖监测、诊断、预防、药代动力学挑战、联合治疗和核心药物,并针对NDM流行环境提出治疗算法。作者指出,目前缺乏高/中等水平证据,推荐基于专家意见。该共识可为临床医生管理重症CRE感染提供专家指导。
要点
- 专家小组通过改良Delphi法对60个临床问题匿名投票,形成46条关键临床共识声明。
- 共识涵盖CRE感染的监测、诊断、预防、药代动力学挑战、联合治疗和核心药物。
- 针对NDM流行环境,专家小组提出了治疗算法。
- 作者指出,管理CRE感染的高/中等水平证据匮乏,推荐基于专家意见。
- 共识可为重症患者CRE感染管理提供专家指导。
适用人群与场景
- 重症患者(critically ill patients)的CRE感染管理。
处置流程与药物剂量
- 针对NDM流行环境,专家小组提出了治疗算法。
研究设计与关键结果
- 11位印度CRE感染多学科专家组成小组,通过系统文献回顾和改良Delphi法匿名投票60个临床问题,形成46条关键临床共识声明。
- 共识涵盖监测、诊断、预防、药代动力学挑战、联合治疗和核心药物。
- 专家小组针对NDM流行环境提出了治疗算法。
证据类型、等级与局限
- 证据类型:专家共识(改良Delphi法)。
- 推荐基于专家意见,因管理CRE感染的高/中等水平证据匮乏。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- 印度CRE感染管理共识(ICONIC),发表于Expert Rev Anti Infect Ther。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: The increasing burden of carbapenem-resistant Enterobacteriaceae (CRE) carriage and infection in different patient settings in India has created an acute need for guidance for clinicians regarding optimal strategies for the management of CRE infection in critically ill patients. Research design and methods: A multidisciplinary panel of 11 Indian experts in CRE infection assembled for comprehensive discussion and consensus development. The experts developed clinical statements through a systematic review of key literature. Main outcome measures: The panel voted anonymously on 60 clinically relevant questions, through a modified Delphi process. Results: Forty-six key clinical consensus statements (CCS) were proposed. The panel reached a consensus on several important issues, providing recommendations on surveillance, diagnosis, prevention, pharmacokinetic challenges, combination therapy, and cornerstone molecules in CRE infections. The panel also proposed a treatment algorithm for NDM-prevalent settings. Conclusion: These consensus statements may offer clinicians expert guidance on the management of CRE infections. There is a dearth of high-/moderate-level evidence on managing CRE infections; the recommendations presented herein are based on expert opinion.
参考来源
- Soman R, Veeraraghavan B, Hegde A, et al. Indian consensus on the management of CRE infection in critically ill patients (ICONIC) - India. Expert Rev Anti Infect Ther. 2019. PMID: 31375039. doi:10.1080/14787210.2019.1647103
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。